AJP - Renal  AJP: Regulatory, Integrative and Comparative Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (February 11, 2009). doi:10.1152/ajprenal.90665.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/4/F819    most recent
90665.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Herbach, N.
Right arrow Articles by Wanke, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herbach, N.
Right arrow Articles by Wanke, R.
Submitted on November 10, 2008
Revised on January 16, 2009
Accepted on February 4, 2009

Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis

Nadja Herbach1*, Irene Schairer1, Andreas Blutke1, Sabine Kautz1, Angela Siebert1, Burkhard Göke, Eckhard Wolf, and Ruediger Wanke

1 University of Munich

* To whom correspondence should be addressed. E-mail: n.herbach{at}lmu.de.

Objective: Diabetic nephropathy is the leading cause of end-stage renal disease and the largest contributor to the total cost of diabetes care. Rodent models are excellent tools to gain more insight into the pathogenesis of diabetic nephropathy. In the present study we characterize the age-related sequence of diabetes-associated kidney lesions in GIPRdn transgenic mice, a novel mouse model of early onset diabetes mellitus. Research Design and Methods: Clinical-chemical analyses, as well as qualitative and quantitative morphological analyses of the kidneys of GIPRdn transgenic animals and non-transgenic littermate controls were performed at 3, 8, 20 and 28 weeks of age. Results: Early renal changes of transgenic mice consisted of podocyte hypertrophy, reduced numerical volume density of podocytes in glomeruli, and homogenous thickening of the glomerular basement membrane, followed by renal and glomerular hypertrophy as well as mesangial expansion and matrix accumulation. At 28 weeks of age, glomerular damage was most prominent, including advanced glomerulosclerosis, tubulointerstitial lesions and proteinuria. Real-time PCR demonstrated increased glomerular expression of collagen type IV alpha 1, fibronectin, and Tgfb1. Immunohistochemistry revealed increased mesangial deposition of collagen type IV, fibronectin and laminin. Conclusion: The present study shows that GIPRdn transgenic mice exhibit renal changes that closely resemble diabetes-associated kidney alterations in humans. Data particularly from male transgenic mice indicate that podocyte hypertrophy is directly linked to hyperglycemia, without the influence of mechanical stress. GIPRdn transgenic mice are considered an excellent new tool to study the mechanisms involved in onset and progression of diabetic nephropathy.




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
N. M. Goldenberg and M. Silverman
Rab34 and its effector munc13-2 constitute a new pathway modulating protein secretion in the cellular response to hyperglycemia
Am J Physiol Cell Physiol, October 1, 2009; 297(4): C1053 - C1058.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.